Telomir Pharmaceuticals, Inc.'s total assets for Q2 2025 were $829.61K, an increase of 68.90% from the previous quarter. TELO total liabilities were $348.39K for the fiscal quarter, a -46.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.